STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.
Learn why cytotoxicity test failures are common in medical devices and discover systematic approaches to identify root causes ...
Dublin, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The "Biocompatibility Testing Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Senior executives in healthcare ...
OTTAWA, ON, April 29, 2025 /CNW/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology company focused on cellulose-based regenerative medicine, today announced the completion of ISO 10993 ...
Image of an in vitro irritation test courtesy Nelson Laboratories. Biocompatibility testing requirements for medical devices are changing. "A lot of things are happening, on all fronts," Thor Rollins, ...
(Nanowerk Spotlight) Any drug intended for systemic administration and all medical devices which will contact blood (e.g. oxygenators, tubing, catheters, artificial hearts) must undergo thorough ...
NEW YORK, NY, UNITED STATES, January 26, 2026 /EINPresswire.com/ — STEMart, a US-based provider of comprehensive services for all phases of medical device ...
Cellulose dermal filler achieves critical biocompatibility milestones, paving the way for clinical trials OTTAWA, ON, April 29, 2025 /CNW/ - Spiderwort Biotechnologies Inc., a pioneering biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results